Domača stranGEHC • NASDAQ
add
GE HealthCare Technologies Inc
68,42 $
Po zaprtju:(0,42 %)+0,29
68,71 $
Konec trgovanja: 25. apr., 16:50:00 GMT -4 · USD · NASDAQ · Izjava
Prejšnji trg. dan.
67,05 $
Dnevni razpon
67,93 $ - 70,82 $
Letni razpon
57,65 $ - 94,80 $
Tržna kapitalizacija
31,33 mrd. USD
Povprečni obseg
5,40 mio.
Razm. P/E
15,76
Dividendna donosnost
0,20 %
Primarna borza
NASDAQ
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 5,32 mrd. | 2,17 % |
Stroški poslovanja | 1,39 mrd. | −4,07 % |
Čisti dohodek | 721,00 mio. | 78,91 % |
Čista dobičkovnost prihodkov | 13,56 | 75,19 % |
Earnings per share | 1,45 | 22,88 % |
EBITDA | 1,03 mrd. | 20,42 % |
Efektivna davčna stopnja | 11,51 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 2,87 mrd. | 15,20 % |
Skupna sredstva | 33,09 mrd. | 1,96 % |
Skupne obveznosti | 24,44 mrd. | −2,81 % |
Celoten lastniški kapital | 8,65 mrd. | — |
Shares outstanding | 457,30 mio. | — |
Razmerje P/B | 3,63 | — |
Donosnost sredstev | 6,62 % | — |
Donosnost kapitala | 11,89 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 721,00 mio. | 78,91 % |
Denar iz dejavnosti | 913,00 mio. | −13,05 % |
Denar iz naložb | −240,00 mio. | −172,73 % |
Denar iz financiranja | −1,28 mrd. | −41,89 % |
Neto sprememba denarnih sredstev | −679,00 mio. | −889,53 % |
Prost denarni tok | 1,05 mrd. | 12,27 % |
Vizitka
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Generalni direktor
Datum ustanovitve
1994
Sedež organizacije
Spletno mesto
Zaposleni
53.000
